FOXO1 is a direct target of EWS-Fli1 oncogenic fusion protein in Ewing's sarcoma cells

Liu Yang1, Hsien-Ming Hu, Anna Zielinska-Kwiatkowska

  • 1Department of Orthopedics, University of Washington, Seattle, WA 98195, United States. lyang@u.washington.edu

Insights

Ewing's sarcoma cells have an inverse relationship between EWS-Fli1 oncogenic protein and FOXO1 tumor suppressor expression. Suppressing EWS-Fli1 increases FOXO1, suggesting its role in Ewing's family tumors.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Ewing's family of tumors (EFTs) are aggressive bone and soft tissue cancers.
  • A hallmark of EFTs is the t(11;22) chromosomal translocation, creating the oncogenic EWS-Fli1 fusion protein.
  • The precise mechanisms by which EWS-Fli1 drives tumorigenesis are not fully elucidated.

Purpose of the Study:

  • To investigate the impact of EWS-Fli1 on gene expression in EFTs.
  • To identify novel targets of EWS-Fli1, focusing on the tumor suppressor FOXO1.
  • To characterize the regulatory relationship between EWS-Fli1 and FOXO1 in EFTs.

Main Methods:

  • DNA microarray analysis was performed following siRNA-mediated knockdown of EWS-Fli1.
  • A doxycycline-inducible siRNA system was established for stable and reversible EWS-Fli1 knockdown in EFT cells.
  • FOXO1 expression, promoter activity, and EWS-Fli1 binding to the FOXO1 promoter were assessed.

Main Results:

  • EWS-Fli1 knockdown led to increased expression of known repressed genes like DKK1 and p57.
  • FOXO1 expression and promoter activity were inversely correlated with EWS-Fli1 protein levels.
  • EWS-Fli1 binding to the FOXO1 promoter decreased upon EWS-Fli1 knockdown.

Conclusions:

  • EWS-Fli1 directly suppresses FOXO1 expression in Ewing's sarcoma cells.
  • The EWS-Fli1-mediated repression of FOXO1 may contribute to the cellular transformation observed in EFTs.
  • Targeting the EWS-Fli1/FOXO1 axis presents a potential therapeutic strategy for Ewing's family tumors.

Related Concept Videos

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which results in tumor...
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which results in tumor...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...